Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:170-174
Published online before print June 21, 2004, doi: 10.1161/01.HYP.0000135250.57004.19
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
44/2/170    most recent
01.HYP.0000135250.57004.19v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palatini, P.
Right arrow Articles by Pessina, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palatini, P.
Right arrow Articles by Pessina, A. C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies
Right arrow Other diagnostic testing
Right arrow Epidemiology

(Hypertension. 2004;44:170.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Prevalence and Clinical Significance of Isolated Ambulatory Hypertension in Young Subjects Screened for Stage 1 Hypertension

Paolo Palatini; Mikolaj Winnicki; Massimo Santonastaso; Lucio Mos; Daniele Longo; Vania Zaetta; Marta Dal Follo; Tiziano Biasion; Achille C. Pessina

From the Clinica Medica 4 (P.P., M.W., D.L., V.Z., A.C.P.), University of Padova; Town Hospital (M.S.), Vittorio Veneto; Town Hospital (L.M.), San Daniele del Friuli; Town Hospital (M.D.F.), Trento; and Town Hospital (T.B.), Rovereto-Ala, Italy.

Correspondence to Professor Paolo Palatini, MD, trial coordinator, Clinica Medica 4, University of Padova via Giustiniani, 2-35128 Padova, Italy. E-mail palatini{at}unipd.it

Little is known about the clinical significance of isolated ambulatory hypertension, a condition characterized by low office but elevated ambulatory blood pressure. This study aimed to investigate the prevalence and the predictive value of isolated ambulatory hypertension diagnosed after 3 months of observation for the development of sustained hypertension within a cohort of 871 never-treated stage-1 hypertensive subjects. The study end point was progression to more severe hypertension and need of antihypertensive medication. In 244 subjects (28%), clinic blood pressure declined to <140/90 mm Hg after 3 months. Of these, 124 (14.2% of total) had low clinic and ambulatory blood pressures after 3 months (nonhypertensive subjects), whereas 120 subjects (13.8% of total) showed low clinic but elevated ambulatory blood pressure (isolated ambulatory hypertension). During the 6 years of observation, the number of end points based on multiple clinic blood pressure readings progressively increased from the nonhypertensive subjects (19%) to the subjects with isolated ambulatory hypertension (35%) and to the subjects with high clinic and high ambulatory blood pressures (65%, P<0.0001). In an adjusted proportional hazard model, isolated ambulatory hypertension status was associated with a 2.2 (P=0.02) increase in the risk of reaching the end point in comparison with the nonhypertensive subjects. Final ambulatory systolic blood pressure was also higher in the former than the latter (P=0.03). Our results indicate that among subjects screened for stage 1 hypertension, individuals with isolated ambulatory hypertension after 3 months of observation have increased risk of developing sustained hypertension in later life compared with subjects in whom both clinic and ambulatory blood pressures are normal.


Key Words: blood pressure monitoring, ambulatory • hypertension, detection and control




This article has been cited by other articles:


Home page
HypertensionHome page
E. O'Brien
Unmasking Hypertension
Hypertension, April 1, 2005; 45(4): 481 - 482.
[Full Text] [PDF]


Home page
HypertensionHome page
E. Lurbe, I. Torro, V. Alvarez, T. Nawrot, R. Paya, J. Redon, and J. A. Staessen
Prevalence, Persistence, and Clinical Significance of Masked Hypertension in Youth
Hypertension, April 1, 2005; 45(4): 493 - 498.
[Abstract] [Full Text] [PDF]